FDA Guidance
Official FDA guidance documents for medical devices and radiation-emitting products
106 resourcesPresenting Risk Information in Prescription Drug and Medical Device Promotion
Draft FDA guidance on labeling. Published 2009 by CDRH/CBER.
View DocumentHumanitarian Use Device (HUD) Designations
Final FDA guidance on hde. Published 2013 by CDRH/CBER.
View DocumentGuidance for the Use of Bayesian Statistics in Medical Device Clinical Trials
Final FDA guidance on clinical evidence. Published 2010 by CDRH/CBER.
View DocumentModifications to Devices Subject to Premarket Approval (PMA) — PMA Supplement Decision-Making Process
Final FDA guidance on pma. Published 2008 by CDRH/CBER.
View DocumentHuman Factors Studies and Related Clinical Study Considerations in Combination Product Design and Development
Final FDA guidance on human factors. Published 2016 by CDRH/CBER.
View DocumentRadio Frequency Wireless Technology in Medical Devices
Final FDA guidance on electrical safety. Published 2013 by CDRH/CBER.
View DocumentMedical Device Classification Product Codes
Final FDA guidance on classification. Published 2013 by CDRH/CBER.
View DocumentProviding Information about Pediatric Uses of Medical Devices
Final FDA guidance on pediatric devices. Published 2014 by CDRH/CBER.
View DocumentTypes of Communication During the Review of Medical Device Submissions
Final FDA guidance on submission process. Published 2014 by CDRH/CBER.
View DocumentDesign Considerations for Pivotal Clinical Investigations for Medical Devices
Final FDA guidance on clinical evidence. Published 2013 by CDRH/CBER.
View DocumentInvestigational Device Exemptions (IDEs) for Early Feasibility Medical Device Clinical Studies
Final FDA guidance on ide. Published 2013 by CDRH/CBER.
View DocumentReprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling
Final FDA guidance on labeling. Published 2015 by CDRH/CBER.
View DocumentDesign Considerations for Devices Intended for Home Use
Final FDA guidance on design controls. Published 2014 by CDRH/CBER.
View DocumentFDA Decisions for Investigational Device Exemption Clinical Investigations
Final FDA guidance on ide. Published 2014 by CDRH/CBER.
View DocumentIn Vitro Companion Diagnostic Devices
Final FDA guidance on ivd & diagnostics. Published 2014 by CDRH/CBER.
View DocumentBalancing Premarket and Postmarket Data Collection for Devices Subject to Premarket Approval
Final FDA guidance on pma. Published 2015 by CDRH/CBER.
View DocumentPatient Preference Information — Voluntary Submission and Review in PMA/HDE/De Novo
Final FDA guidance on patient engagement. Published 2016 by CDRH/CBER.
View DocumentAdaptive Designs for Medical Device Clinical Studies
Final FDA guidance on clinical evidence. Published 2016 by CDRH/CBER.
View DocumentLeveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices
Final FDA guidance on pediatric devices. Published 2016 by CDRH/CBER.
View DocumentEvaluation and Reporting of Age-, Race-, and Ethnicity-Specific Data in Medical Device Clinical Studies
Final FDA guidance on clinical evidence. Published 2017 by CDRH/CBER.
View DocumentDesign Considerations and Premarket Submission Recommendations for Interoperable Medical Devices
Final FDA guidance on interoperability. Published 2017 by CDRH/CBER.
View DocumentFactors to Consider When Making Benefit-Risk Determinations for Medical Device IDEs
Final FDA guidance on ide. Published 2017 by CDRH/CBER.
View DocumentPostmarket Management of Cybersecurity in Medical Devices
Final FDA guidance on cybersecurity. Published 2016 by CDRH/CBER.
View DocumentFDA and Industry Actions on PMA Submissions: Effect on FDA Review Clock and Goals
Final FDA guidance on pma. Published 2017 by CDRH/CBER.
View Document